UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Development of a CRISPR-based gene therapy approach to correct duplications causing Duchenne Muscular Dystrophy

Pini, Veronica; (2019) Development of a CRISPR-based gene therapy approach to correct duplications causing Duchenne Muscular Dystrophy. Doctoral thesis (Ph.D), UCL (University College London). Green open access

[thumbnail of Final thesis VP.pdf]
Preview
Text
Final thesis VP.pdf - Accepted Version

Download (13MB) | Preview

Abstract

Duchenne Muscular Dystrophy is a severe neurodegenerative disorder caused by deletions, duplications or point mutations in the DMD gene, which encodes dystrophin. In absence of dystrophin, muscle fibres degenerate and patients become wheelchair dependent by their early teens. Cardiac and respiratory muscles are also affected, causing premature death by the third decade of life. Among the approaches currently being tested in clinical trials to treat this disease, none is suitable to permanently restore dystrophin by removing either small or large multi-exon dystrophin duplications, which account for 10-15% of DMD cases. In this thesis, I designed a genome editing approach to correct duplications in the DMD gene by using a single CRISPR/Cas9 target site. First, I identified a CRISPR/Cas9 nuclease able to efficiently target DMD intron 9, which would be suitable for gene editing in patients harbouring DMD duplications in the mutational hotspot 2-201. Then, I tested both integrating lentiviral particles and nuclear electroporation as tools to deliver and express CRISPR/Cas9 in patient-derived cells carrying different dystrophin duplications. Patient-derived myoblasts allowed me to assess dystrophin restoration at the genomic, transcriptional and protein level by means of the T7 assay, quantitative-PCR and western blot, respectively. I confirmed dystrophin correction in transduced as well as electroporated cells expressing CRISPR/Cas9, and I demonstrated that both a constitutive and a transient nuclease expression led to a similar extent of protein restoration of around 50%. These outcomes allowed me to conclude that CRISPR/Cas9 editing tool is a suitable approach to remove large genomic duplications in vitro. Furthermore, the data presented in this thesis provides the basis for the design of new therapeutic approaches to be tested in vivo in Duchenne Muscular Dystrophy animal models. These include both in vivo CRISPR/Cas9-mediated gene therapy and cell-therapy based on transplantation of ex vivo corrected myoblasts expressing corrected wild-type dystrophin.

Type: Thesis (Doctoral)
Qualification: Ph.D
Title: Development of a CRISPR-based gene therapy approach to correct duplications causing Duchenne Muscular Dystrophy
Event: UCL
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Copyright © The Author 2019. Original content in this thesis is licensed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) Licence (https://creativecommons.org/licenses/by/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request.
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10083022
Downloads since deposit
247Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item